Covestor LTD Bristol Myers Squibb CO Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Covestor LTD holds 6,318 shares of BMY stock, worth $367,897. This represents 0.2% of its overall portfolio holdings.

Number of Shares

6,318

Previous 6,341 0.36%

Holding current value

$367,897

Previous $263,000 24.33%

% of portfolio

0.2%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$39.66 - $51.75 $912 - $1,190	-23 Reduced 0.36%	6,318 $327,000
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $31,515 - $41,491	783 Added 14.09%	6,341 $263,000
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $48,891 - $55,433	1,019 Added 22.45%	5,558 $302,000
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $3,781 - $4,512	78 Added 1.75%	4,539 $233,000
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $58,584 - $65,506	1,012 Added 29.34%	4,461 $258,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $95,437 - $105,968	-1,498 Reduced 30.28%	3,449 $221,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $26,481 - $30,035	403 Added 8.87%	4,947 $343,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $30,199 - $35,760	-441 Reduced 8.85%	4,544 $326,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $42 - $24,896	324 Added 6.95%	4,985 $354,000
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $189,465 - $208,667	2,609 Added 127.14%	4,661 $359,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $66,521 - $79,765	1,082 Added 111.55%	2,052 $150,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $52,021 - $60,644	970 New	970 $61,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account